Our current data indicate that the expression levels of the SESN1 and/or SESN2 genes are often diminished in human lung cancers and suppression of SESN1/2 may support tumor growth and/or progression through such mechanisms as stimulation of cell growth, proliferation, mutagenesis, and angiogenesis [25]. The gene discussed is SESN2; the disease is neoplasm.